Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,405 | 272 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,109 | 58 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $890.69 | 46 | $0 (2024) |
| Lilly USA, LLC | $527.18 | 26 | $0 (2024) |
| ABBVIE INC. | $413.48 | 13 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $307.02 | 18 | $0 (2023) |
| GlaxoSmithKline, LLC. | $264.96 | 16 | $0 (2024) |
| Exact Sciences Corporation | $254.78 | 12 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $238.07 | 13 | $0 (2024) |
| Dynavax Technologies Corporation | $202.70 | 5 | $0 (2024) |
| Amgen Inc. | $198.23 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,181 | 57 | AstraZeneca Pharmaceuticals LP ($342.15) |
| 2023 | $925.99 | 54 | Novo Nordisk Inc ($194.95) |
| 2022 | $1,342 | 58 | ABBVIE INC. ($295.88) |
| 2021 | $432.23 | 20 | Novo Nordisk Inc ($161.33) |
| 2020 | $92.01 | 6 | Novo Nordisk Inc ($46.50) |
| 2019 | $261.29 | 5 | Dynavax Technologies Corporation ($124.98) |
| 2018 | $676.79 | 39 | AstraZeneca Pharmaceuticals LP ($248.95) |
| 2017 | $493.44 | 33 | SANOFI-AVENTIS U.S. LLC ($105.54) |
All Payment Transactions
272 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $34.67 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Oncology | ||||||
| 09/30/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Hepatitis B Vaccine | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Respiratory | ||||||
| 08/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Obesity | ||||||
| 08/15/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Inflammation | ||||||
| 08/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: DIABETES | ||||||
| 08/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Oncology | ||||||
| 07/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Inflammation | ||||||
| 07/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/24/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Neurology | ||||||
| 06/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Oncology | ||||||
| 06/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Diabetes | ||||||
| 06/10/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: ADHD | ||||||
| 06/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Obesity | ||||||
| 05/29/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 448 | 624 | $198,444 | $57,042 |
| 2022 | 7 | 474 | 651 | $197,118 | $58,891 |
| 2021 | 6 | 229 | 291 | $86,062 | $25,300 |
| 2020 | 3 | 57 | 97 | $31,604 | $8,045 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 185 | 355 | $119,523 | $29,442 | 24.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 131 | 131 | $47,159 | $16,471 | 34.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 16 | 16 | $11,504 | $4,492 | 39.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 25 | $11,611 | $2,942 | 25.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 27 | 28 | $3,612 | $2,000 | 55.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 33 | 34 | $2,584 | $1,028 | 39.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 16 | $1,216 | $483.84 | 39.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 19 | $1,235 | $183.32 | 14.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 201 | 373 | $120,852 | $29,814 | 24.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 110 | 110 | $38,390 | $14,171 | 36.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 27 | 27 | $19,413 | $7,519 | 38.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 42 | 44 | $5,676 | $3,006 | 53.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 15 | $6,555 | $2,025 | 30.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 46 | 48 | $3,648 | $1,377 | 37.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 34 | 34 | $2,584 | $979.78 | 37.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 110 | 169 | $54,756 | $15,002 | 27.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 41 | 41 | $14,309 | $5,405 | 37.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $8,466 | $1,956 | 23.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 23 | 23 | $2,967 | $1,501 | 50.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 17 | $3,740 | $1,037 | 27.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 24 | 24 | $1,824 | $398.16 | 21.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 29 | 67 | $21,708 | $5,400 | 24.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 16 | 16 | $6,816 | $1,871 | 27.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 14 | $3,080 | $775.01 | 25.2% |
About Dr. Rodolfo Torres, M.D
Dr. Rodolfo Torres, M.D is a Family Medicine healthcare provider based in Winter Springs, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2005. The National Provider Identifier (NPI) number assigned to this provider is 1649261496.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rodolfo Torres, M.D has received a total of $5,405 in payments from pharmaceutical and medical device companies, with $1,181 received in 2024. These payments were reported across 272 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,405).
As a Medicare-enrolled provider, Torres has provided services to 1,208 Medicare beneficiaries, totaling 1,663 services with total Medicare billing of $149,278. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Winter Springs, FL
- Active Since 11/01/2005
- Last Updated 08/04/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1649261496
Products in Payments
- Ozempic (Drug) $527.75
- FARXIGA (Drug) $419.18
- MOUNJARO (Drug) $391.33
- Rybelsus (Drug) $335.96
- UBRELVY (Drug) $277.69
- JARDIANCE (Drug) $272.37
- Cologuard Collection Kit (Device) $254.78
- Heplisav-B (Drug) $202.70
- AIRSUPRA (Drug) $181.66
- SHINGRIX (Biological) $163.27
- Victoza (Drug) $114.75
- Kerendia (Drug) $113.94
- KRYSTEXXA (Biological) $107.27
- TOUJEO (Drug) $106.08
- QULIPTA (Drug) $105.53
- SYMBICORT (Drug) $98.03
- BYDUREON (Drug) $93.98
- Otezla (Drug) $87.43
- ADVAIR (Drug) $86.65
- TOUJEO (Biological) $84.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Winter Springs
Jason Guevara, M.d, M.D
Family Medicine — Payments: $5,746
Dr. Joseph Johnson, M.d, M.D
Family Medicine — Payments: $3,833
Salma Ismail, M.d, M.D
Family Medicine — Payments: $3,574
Dr. Daniel Cochran, Md, MD
Family Medicine — Payments: $2,900
John Treharne, Md, MD
Family Medicine — Payments: $1,230
Dr. Joan Coupland, Md, MD
Family Medicine — Payments: $670.08